{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:08:44Z","timestamp":1792238924199,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["T32CA193111"],"award-info":[{"award-number":["T32CA193111"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["F30CA247020"],"award-info":[{"award-number":["F30CA247020"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["T32CA009161"],"award-info":[{"award-number":["T32CA009161"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1106545"],"award-info":[{"award-number":["APP1106545"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Airc Italian Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016828","name":"Stanford Genome Technology Center","doi-asserted-by":"publisher","award":["P30CA016087"],"award-info":[{"award-number":["P30CA016087"]}],"id":[{"id":"10.13039\/100016828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000654","name":"Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014597","name":"LAM Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016471","name":"Agios Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K00CA212460"],"award-info":[{"award-number":["K00CA212460"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA222504"],"award-info":[{"award-number":["R37CA222504"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30CA243205"],"award-info":[{"award-number":["F30CA243205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA76584"],"award-info":[{"award-number":["R01CA76584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA227649"],"award-info":[{"award-number":["R01CA227649"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35CA210263"],"award-info":[{"award-number":["R35CA210263"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM136250"],"award-info":[{"award-number":["R35GM136250"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA193111"],"award-info":[{"award-number":["T32CA193111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA009161"],"award-info":[{"award-number":["T32CA009161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016087"],"award-info":[{"award-number":["P30CA016087"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NHMRC\/APP1106545"],"award-info":[{"award-number":["NHMRC\/APP1106545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH\/F30CA247020"],"award-info":[{"award-number":["NIH\/F30CA247020"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.cell.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T10:29:36Z","timestamp":1640600976000},"page":"169-183.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion"],"prefix":"10.1016","volume":"185","author":[{"given":"Antonio","family":"Marzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Puccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Alcantara","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo A.","family":"Arbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren L.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Bar-Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-1624","authenticated-orcid":false,"given":"Thales","family":"Papagiannakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2021.12.005_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.005_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"issue":"Suppl 3","key":"10.1016\/j.cell.2021.12.005_bib3","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.3816\/CLC.2008.s.014","article-title":"Multitargeted inhibitors in lung cancer: new clinical data","volume":"9","author":"Bar","year":"2008","journal-title":"Clin. Lung Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.cell.2021.12.005_bib4","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.21037\/jtd.2018.11.102","article-title":"Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors","volume":"11","author":"Berland","year":"2019","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.cell.2021.12.005_bib5","doi-asserted-by":"crossref","first-page":"e000442","DOI":"10.1136\/esmoopen-2018-000442","article-title":"Implementing TMB measurement in clinical practice: considerations on assay requirements","volume":"4","author":"B\u00fcttner","year":"2019","journal-title":"ESMO Open"},{"key":"10.1016\/j.cell.2021.12.005_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.tcb.2019.06.005","article-title":"Defining and Modulating \u2018BRCAness\u2019","volume":"29","author":"Byrum","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2021.12.005_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","article-title":"The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling","volume":"54","author":"Cai","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.005_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2021.12.005_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.21037\/atm.2019.11.52","article-title":"Pan-cancer analysis of KEAP1 mutations as biomarkers for immunotherapy outcomes","volume":"8","author":"Chen","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cell.2021.12.005_bib55","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1074\/mcp.M500227-MCP200","article-title":"Fluorescent proteins as proteomic probes","volume":"4","author":"Cristea","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cell.2021.12.005_bib11","doi-asserted-by":"crossref","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.005_bib12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cbdd.13166","article-title":"An overview on Vadimezan (DMXAA): The vascular disrupting agent","volume":"91","author":"Daei Farshchi Adli","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cell.2021.12.005_bib13","doi-asserted-by":"crossref","first-page":"17735","DOI":"10.18632\/oncotarget.24878","article-title":"Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer","volume":"9","author":"Dansonka-Mieszkowska","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2021.12.005_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4161\/trns.21904","article-title":"Akt1, EMSY, BRCA2 and type I IFN signaling: a novel arm of the IFN response","volume":"3","author":"Ezell","year":"2012","journal-title":"Transcription"},{"key":"10.1016\/j.cell.2021.12.005_bib49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2159-8290.CD-17-0915","article-title":"CDK4\/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation","volume":"8","author":"Deng","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.cell.2021.12.005_bib15","doi-asserted-by":"crossref","first-page":"E613","DOI":"10.1073\/pnas.1115029109","article-title":"The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY","volume":"109","author":"Ezell","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.12.005_bib47","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/spe.4380211102","article-title":"Graph drawing by force-directed placement","volume":"21","author":"Fruchterman","year":"1991","journal-title":"Software Pract Exper"},{"key":"10.1016\/j.cell.2021.12.005_bib52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2017.01.006","article-title":"Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis","volume":"31","author":"Gardner","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-1-61779-998-3_27","article-title":"I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks","volume":"920","author":"Gunn","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cell.2021.12.005_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(03)00933-4","article-title":"The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis","volume":"115","author":"Haber","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","article-title":"The Complex Interplay between Antioxidants and ROS in Cancer","volume":"30","author":"Harris","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2021.12.005_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.21037\/tlcr.2018.08.04","article-title":"Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?","volume":"7","author":"Heeke","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.cell.2021.12.005_bib19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/cancers11091271","article-title":"In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients","volume":"11","author":"Heeke","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2021.12.005_bib20","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/cncr.32079","article-title":"High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum","volume":"125","author":"Hollis","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.cell.2021.12.005_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0092-8674(03)00930-9","article-title":"EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer","volume":"115","author":"Hughes-Davies","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1089\/ars.2010.3222","article-title":"Discovery of the negative regulator of Nrf2, Keap1: a historical overview","volume":"13","author":"Itoh","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cell.2021.12.005_bib23","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2-Keap1 signaling pathway in cancer","volume":"27","author":"Jaramillo","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2021.12.005_bib24","doi-asserted-by":"crossref","first-page":"13792","DOI":"10.18632\/oncotarget.14637","article-title":"The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair","volume":"8","author":"Jelinic","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2021.12.005_bib25","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/cncr.32135","article-title":"Clarifying the role of EMSY in DNA repair in ovarian cancer","volume":"125","author":"Kondrashova","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.cell.2021.12.005_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.005_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib51","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cell.2019.06.003","article-title":"Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1","volume":"178","author":"Lignitto","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nm0204-127","article-title":"EMSY, a BRCA-2 partner in crime","volume":"10","author":"Livingston","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.12.005_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2021.12.005_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12885-017-3488-x","article-title":"Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families","volume":"17","author":"M\u00e4\u00e4tt\u00e4","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cell.2021.12.005_bib30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.abg5784","article-title":"The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation","volume":"373","author":"Martin","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.005_bib54","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.molcel.2018.11.003","article-title":"The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers","volume":"73","author":"Marzio","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib31","doi-asserted-by":"crossref","first-page":"e000706","DOI":"10.1136\/esmoopen-2020-000706","article-title":"STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort","volume":"5","author":"Papillon-Cavanagh","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.cell.2021.12.005_bib50","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1101\/gad.13.20.2633","article-title":"XRCC3 promotes homology-directed repair of DNA damage in mammalian cells","volume":"13","author":"Pierce","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.cell.2021.12.005_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/14728222.2019.1654458","article-title":"Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers","volume":"23","author":"Przybycinski","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cell.2021.12.005_bib33","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.005_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the Hallmarks of Cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib35","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","article-title":"Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis","volume":"23","author":"Romero","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.12.005_bib36","doi-asserted-by":"crossref","first-page":"101299","DOI":"10.1016\/j.smim.2019.101299","article-title":"Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints","volume":"43","author":"Saleiro","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cell.2021.12.005_bib37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I Interferon in Chronic Virus Infection and Cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2021.12.005_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2554494","article-title":"p53: a frequent target for genetic abnormalities in lung cancer","volume":"246","author":"Takahashi","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.005_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.immuni.2019.08.004","article-title":"The Immune Landscape of Cancer","volume":"51","author":"Thorsson","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2021.12.005_bib40","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.molcel.2021.01.020","article-title":"Systematic characterization of mutations altering protein degradation in human cancers","volume":"81","author":"Tokheim","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib41","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1074\/jbc.M115.701227","article-title":"Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131","volume":"291","author":"Varier","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2021.12.005_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molcel.2014.03.041","article-title":"The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31","volume":"54","author":"Vir\u00e9","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib43","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1158\/1535-7163.MCT-15-0374","article-title":"Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition","volume":"14","author":"Wiegmans","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cell.2021.12.005_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell Syst"},{"key":"10.1016\/j.cell.2021.12.005_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccell.2018.03.005","article-title":"Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies","volume":"33","author":"Zappasodi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2021.12.005_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"STING: a master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421014276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421014276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:16:15Z","timestamp":1777475775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867421014276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0092867421014276"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2021.12.005","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}